Individual breast cancer risk assessment in underserved populations: Integrating empirical bioethics and health disparities research

Journal of Health Care for the Poor and Underserved

Volumn 23, Issue 4 SUPPL., 2012, Pages 34-46

  Anderson, Emily E ^a   Hoskins, Kent ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Bioethics; Ethics; Health disparities; Risk assessment; Risk communication

Indexed keywords

ADULT; AGED; ATTITUDE TO HEALTH; BIOETHICS; BREAST TUMOR; EARLY DIAGNOSIS; EMPIRICAL RESEARCH; ETHICS; ETHNOLOGY; FEMALE; HEALTH CARE DISPARITY; HEALTH SERVICES RESEARCH; HUMAN; MIDDLE AGED; MINORITY GROUP; NOTE; ORGANIZATION AND MANAGEMENT; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; UNITED STATES; VULNERABLE POPULATION;

ADULT; AGED; ATTITUDE TO HEALTH; BIOETHICS; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; EMPIRICAL RESEARCH; FEMALE; HEALTH SERVICES RESEARCH; HEALTHCARE DISPARITIES; HUMANS; MIDDLE AGED; MINORITY GROUPS; RISK ASSESSMENT; UNITED STATES; VULNERABLE POPULATIONS;

EID: 84872251159     PISSN: 10492089     EISSN: 15486869     Source Type: Journal    
DOI: 10.1353/hpu.2012.0178     Document Type: Note

References (64)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96.
2. Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006 May-Jun; 56(3):168-83.
3. Sabatino SA, Coates RJ, Uhler RJ, et al. Disparities in mammography use among U.S. women aged 40-64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005. Med Care. 2008 Jul;46(7):692-700.
4. Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008 Jan-Feb;58(1):9-31.
5. Sung JF, Alema-Mesah E, Blumenthal DS. Inner city African American women who failed to receive cancer screening following a culturally-appropriate intervention: the role of health insurance. Cancer Detect Prev. 2002;26(1):28-32.
6. DeSantis C, Jemal A, Ward E. Disparities in breast cancer prognostic factors by race, insurance status, and education. Cancer Causes Control. 2010 Sep;21(9):1445-50
7. Gorin SS, Heck JE, Cheng B, et al. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med. 2006 Nov;166(20):2244-52.
8. Smith-Bindman R, Miglioretti D, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006 Apr;144(8): 541-53.
9. Glanz K, Resch N, Lerman C, et al. Black-White differences in factors influencingmammography use among employed female health maintenance organization members. Ethn Health. 1996 Sep;1(3):207-20.
10. Davis S, Stewart S, Bloom J. Increasing the accuracy of perceived breast cancer risk: results from a randomized trial with Cancer Information Service Callers. Prev Med. 2004 Jul;39(1):64-73.
11. Rauscher GH, Ferrans CE, Kaiser K, et al. Misconceptions about breast lumps and delayed medical presentation in urban breast cancer patients. Cancer Epidemiol Bio markers Prev. 2010 Mar;19(3):640-7.
12. Taplin S, Abraham L, Barlow WE, et al. Mammography facility characteristics associated with interpretive accuracy of screening mammography. J Natl Cancer Inst. 2008 Jun;100(12):876-87.
13. Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008 Jan-Feb;58(1):9-31.
14. Hershman DL, Unger JM, Barlow WE, et al. Treatment quality and outcomes of African American versus White breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897. J Clin Oncol. 2009 May;27(13):2157-62.
15. Scofield M. Metropolitan Chicago breast cancer task force reports on progress toward reducing the Black-White disparity. Bexhill-on-Sea, United Kingdom: Medical News Today, 2008 Oct 23. Available at: www.medicalnewstoday.com/articles/126530.php.
16. Mandelblatt JS, Schechter CB, Yabroff KR, et al. Benefits and costs of interventions to improve breast cancer outcomes in African American women. J Clin Oncol. 2004 Jul;22(13):2554-66.
17. Freedman AN, Seminara D, Gail MH, et al. Cancer risk prediction models: a workshop on development, evaluation and application. J Natl Cancer Inst. 2005 May; 97(10): 715-23.
18. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for White females who are being examined annually. J Natl Cancer Inst. 1989 Dec;81(24):1879-86.
19. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritnace of early-onsent breast cancer. Cancer. 1994 Feb;73(3):643-51.
20. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004 Apr;23(7):1110-30.
21. Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med. 2000 Feb;342(8):564-71.
22. Domcheck S, Eisen A, Calzone K, et al. Application of breast cancer risk prediction models in clinical practice. J Clin Oncol. 2003 Feb;21(4):593-601.
23. Hoskins KF, Zwaagstra A, Ranz M. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer. 2006 Oct;107(8):1769-76.
24. Pharoah PD, Antoniou AC, Easton DF, et al. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med. 2008 Jun;358(26):2796-803.
25. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2009 Nov;151(10):716-26.
26. U.S. Preventive Services Taskforce. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005 Sep;143(5):355-61.
27. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89.
28. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009 Jan-Feb;59(1):27-41.
29. Dankwa-Mullan I, Rhee KB, Williams K, et al. The science of eliminating health disparities: summary and analysis of the NIH Summit recommendations. Am J Public Health. 2010 Apr;100(suppl 1):S12-8.
30. Gail MH, Costantino JP, Pee D, et al. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst. 2007 Dec;99(23):1782-92.
31. Mahoney MC, Bevers T, Linos E, et al. Opportunities and strategies for breast cancer prevention through risk reduction. CA Cancer J Clin. 2008 Nov-Dec;58(6):347-71.
32. Janz N, Becker MH. The health belief model: a decade later. Health Educ Q. 1984 Spring;11(1):1-47.
33. Institute of Medicine/Committee on Quality Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy of Sciences, 2001 Mar. Available at: http://www.iom.edu/~/media/Files/Report%20Files/2001/Crossing-the-Quality-Chasm/Quality%20Chasm%202001%20%20report%20brief.pdf.
34. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. 2010 Jul; 363(4):301-4.
35. Buchanan AH, Skinner CS, Rawl SM, et al. Patients' interest in discussing cancer risk and risk management with primary care physicians. Patient Educ Couns. 2005 Apr; 57(1):77-87.
36. Bartle-Haring S, Toviessi P, Katafiasz H. Predicting the use of individualized risk assessment for breast cancer. Womens Health Issues. 2008 Mar-Apr;18(2):100-9.
37. Mays D, Sharff M, DeMarco TA, et al. Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women. Fam Cancer. 2012 Jun 19. [Epub ahead of print.]
38. Mant D, Fowler G. Mass screening: theory and ethics. BMJ. 1990 Apr;300(6729):916-8.
39. Breitsameter C. Medical decision-making and communication of risks: an ethical perspective. J Med Ethics. 2010 Jun;36(6):349-52.
40. Ozanne EM, Klemp JR, Esserman LJ. Breast cancer risk assessment and prevent{stroke}ion: a framework for shared decision-making consultations. Breast J. 2006 Mar-Apr; 12(2):103-13.
41. Lerman C, Rimer B, Trock B, et al. Factors associated with repeat adherence to breast cancer screening. Prev Med. 1990 May;19(3):279-90.
42. Berliner JL, Fay AM. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns. 2007 Jun;16(3):241-60.
43. Lerman C, Lustbader E, Rimer B, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst. 1995 Feb;87(4):286-92.
44. Haynes RB, Sackett DL, Taylor DW, et al. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med. 1978 Oct;299(14):741-4.
45. Bloom JR, Monteross S. Hypertension labeling and sense of well-being. Am J Public Health. 1981 Nov;71(11):1226-32.
46. Mossey JM. Psychosocial consequences of labeling in hypertension. Clin Invest Med. 1981;4(3-4):201-7.
47. Kenen RH. The at-risk health status and technology: a diagnostic invitation and the "gift" of knowing. Soc Sci Med. 1996 Jun;42(11):1545-53.
48. Silverman E, Woloshin S, Schwartz LM, et al. Women's views on breast cancer risk and screening mammography: a qualitative interview study. Med Decis Making. 2001 May-Jun;21(3):231-40.
49. Greenwald HP, Becker SW, Nevitt MC. Delay and non-compliance in cancer detection. A behavioral perspective for health planners. Millbank Mem Fund Q HealthSoc. 1978 Spring;56(2):212-30.
50. Sankar P, Cho MK, Condit CM, et al. Genetic research and health disparities. JAMA. 2004 Jun; 291(24):2985-9.
51. McBride CM, Bowen D, Brody LC, et al. Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med. 2010 May;38(5):556-65.
52. Hay J, Harris JN, Waters EA, et al. Personal communication in primary and secondary cancer prevention: evolving discussions, emerging challenges. J Health Commun. 2009;14(Suppl 1):18-29.
53. Han PK, Lehman TC, Massett H, et al. Conceptual problems in laypersons' understanding of individualized cancer risk: a qualitative study. Health Expect. 2009 Mar; 12(1):4-17.
54. Yamagishi K. When a 12.86% mortality is more dangerous than 24.14%: implications for risk communication. Applied Cognitive Psychol. 1997;11(6):495-506.
55. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science. 1981 Jan;211(4481):453-8.
56. Budescu DV, Weinberg S, Wallsten TS. Decisions based on numerically and verbally expressed uncertainties. J Exp Psychol Hum Percept Perform. 1988;14(2):281-94.
57. Lipkus IM, Biradavolu M, Fenn K, et al. Informing women about their breast cancer risks: truth and consequences. Health Communication. 2001;13(2):205-26.
58. Orom H, Kiviniemi MT, Underwood W III, et al. Perceived cancer risk: why is it lower among non-Whites than Whites? Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3): 746-54.
59. Culver JO, Bowen DJ, Reynolds SE, et al. Breast cancer risk communication: assessment of primary care physicians by standardized patients. Genet Med. 2009 Oct;11(10): 735-41.
60. Clancy C, Collins FS. Patient-centered outcomes research institute: the intersection of science and health care. Sci Transl Med. 2010 Jun;2(37):37cm18.
61. DuBois JM. What counts as empirical research in bioethics and where do we find the stuff? Am J Bioeth. 2009;9(6-7):70-2.
62. Singer PA, Taylor AD, Daar AS, et al. Grand challenges in global health: the ethical, social and cultural program. PLoS Med. 2007 Sep;4(9):e265.
63. Fisher E. Lessons learned from the Ethical, Legal and Social Implications program (ELSI): planning societal implications research for the national nanotechnology program. Technology in Society. 2005 Aug;27(3):321-28.
64. Kon AA. The role of empirical research in bioethics. Am J Bioeth. 2009;9(6-7):59-65.